Proposed Data Collection Submitted for Public Comment and Recommendations, 28615-28617 [2015-12094]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
1. David L. Johnson and Sandra L.
Castetter, both of Kansas City, Missouri;
each individually to acquire over 10
percent; and David L. Johnson and
Sandra L. Castetter, together with Park
GP, LLC, North Kansas City, Missouri,
acting in concert to acquire up to 24.99
percent of the voting shares CCSB
Financial Corp., parent of Clay County
Savings Bank, both of Liberty, Missouri.
Board of Governors of the Federal Reserve
System, May 13, 2015.
Michael J. Lewandowski,
Assistant Secretary of the Board.
[FR Doc. 2015–12034 Filed 5–18–15; 8:45 am]
BILLING CODE 6210–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
The meeting announced below
concerns Building Local Community
Health Leadership for Action on
Preventing Chronic Disease, SIP 15–006,
initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on May 5, 2015, Volume 80,
Number 86, Page 25692. The time and
date should have read as follows:
11:00 a.m.–6:00 p.m.,
May 28, 2015 (Closed).
TIME AND DATE:
FOR FURTHER INFORMATION CONTACT:
tkelley on DSK3SPTVN1PROD with NOTICES
Brenda Colley Gilbert, Ph.D., M.S.P.H.,
Director, Extramural Research Program
Operations and Services, CDC, 4770
Buford Highway NE., Mailstop F–80,
Atlanta, Georgia 30341, Telephone:
(770) 488–6295, BJC4@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity Announcement
(FOA) PS15–1505, Enhancing HIV
Prevention Communication and
Mobilization Efforts through Strategic
Partnerships.
Time and Date: 10:00 a.m.–1:00 p.m., EDT,
Panels 1–5; June 9, 2015 (CLOSED).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters for Discussion: The meeting will
include the initial review, discussion, and
evaluation of applications received in
response to ‘‘Enhancing HIV Prevention
Communication and Mobilization Efforts
through Strategic Partnerships’’ FOA PS15–
1505.
Contact Person for more Information: Lisa
R. Williams, Public Health Analyst, CDC,
1600 Clifton Road, NE., Mailstop E07,
Atlanta, Georgia 30333, Telephone: (404)
639–1877.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–12056 Filed 5–18–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing efforts to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies to take this opportunity to
comment on proposed and/or
continuing information collections, as
required by the Paperwork Reduction
Act of 1995. This notice invites
comment on the proposed information
collection entitled CDC Burden of
Canine Brucellosis Information
Collection. This information collection
will help to estimate canine brucellosis
disease burden in dogs, which will aid
in the determination of the public
health importance of human B. canis
infections, and the potential for
zoonotic transmission.
DATES: Written comments must be
received on or before July 20, 2015.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2015–
0037 by any of the following methods:
• Federal eRulemaking Portal:
Regulation.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
BILLING CODE 4163–18–P
Jkt 235001
Proposed Data Collection Submitted
for Public Comment and
Recommendations
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2015–12054 Filed 5–18–15; 8:45 am]
16:53 May 18, 2015
[60Day–15–15AIS; Docket No. CDC–2015–
0037]
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to
the address listed above.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
VerDate Sep<11>2014
28615
Frm 00037
Fmt 4703
Sfmt 4703
E:\FR\FM\19MYN1.SGM
19MYN1
28616
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
been ascertained. The Council of State
and Territorial Epidemiologists
approved a position statement in 2012
that recommends increased focus on B.
canis, and urges CDC to support the
development of a human diagnostic
assay.
The purpose of this information
collection request is to estimate the
burden of canine brucellosis in the
United States, which will aid in the
determination of the level of public
health importance of human B. canis
infections, and the potential for
transmission of brucellosis from dogs.
An estimate of disease burden in dogs
will provide an idea of potential
transmission between dogs and humans,
and determine the need for future
human public health studies, which is
critical during this time of scarce
resources.
Veterinary diagnostic laboratories
throughout the United States will be
solicited to provide information on the
quantity of test requests and positive
results for Brucella spp. in canines,
outsourcing of clinical testing, statewide policies for reporting of positive
results, and policies for human
exposure to clinical specimens or
isolates.
The laboratories were identified
through multiple sources: A review of
the Animal and Plant Health Inspection
Service-approved Brucella diagnostic
laboratories, the National Animal Health
Laboratory Network laboratories, the
American Association of Veterinary
Laboratory Diagnosticians (AAVLD),
and an Internet search.
The outcomes of this information
collection are to assess the burden of
disease in the animal host (dogs, in this
case), as well as evaluate the knowledge
and practices of occupational exposures
to the organism. The information
collected will be used to guide a longer
term strategy for identification of human
cases, understanding risk factors and
activities associated with zoonotic
transmission, and eventually validation
of a human diagnostic assay. These
strategies will be implemented using
other mechanisms.
The total annual burden is 129 hours.
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
transmit or otherwise disclose the
information.
Proposed Project
CDC Burden of Canine Brucellosis
Information Collection—New—National
Center for Emerging and Zoonotic
Infectious Diseases, Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Canine brucellosis is a bacterial
infection caused by the organism
Brucella canis. Few seroprevalence
studies have been done to estimate the
prevalence of canine brucellosis, most
of which were conducted over 25 years
ago. Two recent reports from Oklahoma
and Wisconsin describe increasing
prevalence in dogs; however, the
national burden is not known. B. canis
is also pathogenic to humans, although
human infections are thought to be rare
in the United States.
Unlike Brucella abortus, B. melitensis,
and B. suis, B. canis is not classified as
a select agent. As a result, laboratory
identification of the organism in
humans does not require reporting to
the Laboratory Response Network.
Brucella species-specific data are not
collected in the Nationally Notifiable
Disease Surveillance System at CDC,
and there are no validated Brucella
canis serological tests to diagnose
disease in humans. For these reasons,
there are no national estimates of B.
canis prevalence in humans or canines.
Additionally, canine infections with
other Brucella species have been
reported in the literature. Zoonotic
transmission is a concern with all
Brucella species pathogenic to humans,
and at least one human infection with
B. suis related to canine contact has
been reported. Neither the prevalence of
canine brucellosis nor the potential risk
of zoonotic spread to humans is known.
There has been interest in human
brucellosis caused by B. canis among
the public health community. However,
the degree of public health importance
of human B. canis infections has not yet
tkelley on DSK3SPTVN1PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Veterinary diagnostic laboratory staff
Burden of Canine Brucellosis Information Collection.
Burden of Canine Brucellosis Information Collection.
Other laboratories .............................
VerDate Sep<11>2014
16:53 May 18, 2015
Jkt 235001
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
Total
burden
(in hrs.)
119
1
1
119
10
1
1
10
E:\FR\FM\19MYN1.SGM
19MYN1
28617
Federal Register / Vol. 80, No. 96 / Tuesday, May 19, 2015 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hrs.)
...........................................................
........................
........................
........................
Type of respondents
Total ...........................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2015–12094 Filed 5–18–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
tkelley on DSK3SPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Time and Date: 11:00 a.m.–2:00 p.m. EDT,
Tuesday, June 9, 2015.
Place: Audio Conference Call via FTS
Conferencing. The USA toll-free, dial-in
number is 1–866–659–0537 and the pass
code is 9933701.
Status: Open to the public. The public is
welcome to submit written comments in
advance of the meeting, to the contact person
below. Written comments received in
advance of the meeting will be included in
the official record of the meeting. The public
is also welcome to listen to the meeting by
joining the teleconference at the USA tollfree, dial-in number, 1–866–659–0537 and
the passcode is 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines, which
have been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
VerDate Sep<11>2014
16:53 May 18, 2015
Jkt 235001
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort (SEC).
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to the
CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August
3, 2001, renewed at appropriate intervals,
most recently, August 3, 2013, and will
expire on August 3, 2015.
Purpose: This Advisory Board is charged
with (a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advising the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class.
Matters for Discussion: The agenda for the
conference call includes: NIOSH evaluation
of SEC Petition for Westinghouse Electric
Corp. facility in Bloomfield, New Jersey
(January 1, 1950–March 1, 2011); Work
Group and Subcommittee Reports; SEC
Petitions Update for the July 2015 Advisory
Board Meeting; Plans for the July 2015
Advisory Board Meeting; and Advisory Board
Correspondence.
The agenda is subject to change as
priorities dictate.
Contact Person for More Information:
Theodore M. Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600 Clifton
Rd. NE., Mailstop: E–20, Atlanta, Georgia
30333, Telephone (513) 533–6800, Toll Free
1–800–CDC–INFO, Email ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Centers for Disease Control and
Prevention
World Trade Center Health Program
Scientific/Technical Advisory
Committee: Notice of Charter Renewal
This gives notice under Public Law
111–347 (The James Zadroga 9/11
Health and Compensation Act of 2010)
and the Federal Advisory Committee
Act (Pub. L. 92–463) of October 6, 1972,
that the World Trade Center Health
Program Scientific/Technical Advisory
Committee, Centers for Disease Control
and Prevention, Department of Health
and Human Services, has been renewed
for a 2-year period through May 12,
2017.
For information, contact person for
more information: Paul J. Middendorf,
Ph.D., Designated Federal Officer,
National Institute for Occupational
Safety and Health, Centers for Disease
Control and Prevention, Department of
Health and Human Services, 2400
Century Parkway NE., Mail Stop E–20,
Atlanta, Georgia 30345, telephone 1
(888) 982–4748; email: wtc-stac@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2015–12058 Filed 5–18–15; 8:45 am]
BILLING CODE 4163–18–P
[FR Doc. 2015–12059 Filed 5–18–15; 8:45 am]
BILLING CODE 4163–18–P
Frm 00039
Fmt 4703
Sfmt 9990
129
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
PO 00000
Total
burden
(in hrs.)
E:\FR\FM\19MYN1.SGM
19MYN1
]]>Agencies
[Federal Register Volume 80, Number 96 (Tuesday, May 19, 2015)]
[Notices]
[Pages 28615-28617]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-12094]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-15-15AIS; Docket No. CDC-2015-0037]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing efforts to reduce public burden and maximize the
utility of government information, invites the general public and other
Federal agencies to take this opportunity to comment on proposed and/or
continuing information collections, as required by the Paperwork
Reduction Act of 1995. This notice invites comment on the proposed
information collection entitled CDC Burden of Canine Brucellosis
Information Collection. This information collection will help to
estimate canine brucellosis disease burden in dogs, which will aid in
the determination of the public health importance of human B. canis
infections, and the potential for zoonotic transmission.
DATES: Written comments must be received on or before July 20, 2015.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2015-
0037 by any of the following methods:
Federal eRulemaking Portal: Regulation.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and
[[Page 28616]]
instruments, contact the Information Collection Review Office, Centers
for Disease Control and Prevention, 1600 Clifton Road NE., MS-D74,
Atlanta, Georgia 30329; phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Proposed Project
CDC Burden of Canine Brucellosis Information Collection--New--
National Center for Emerging and Zoonotic Infectious Diseases, Centers
for Disease Control and Prevention (CDC).
Background and Brief Description
Canine brucellosis is a bacterial infection caused by the organism
Brucella canis. Few seroprevalence studies have been done to estimate
the prevalence of canine brucellosis, most of which were conducted over
25 years ago. Two recent reports from Oklahoma and Wisconsin describe
increasing prevalence in dogs; however, the national burden is not
known. B. canis is also pathogenic to humans, although human infections
are thought to be rare in the United States.
Unlike Brucella abortus, B. melitensis, and B. suis, B. canis is
not classified as a select agent. As a result, laboratory
identification of the organism in humans does not require reporting to
the Laboratory Response Network. Brucella species-specific data are not
collected in the Nationally Notifiable Disease Surveillance System at
CDC, and there are no validated Brucella canis serological tests to
diagnose disease in humans. For these reasons, there are no national
estimates of B. canis prevalence in humans or canines.
Additionally, canine infections with other Brucella species have
been reported in the literature. Zoonotic transmission is a concern
with all Brucella species pathogenic to humans, and at least one human
infection with B. suis related to canine contact has been reported.
Neither the prevalence of canine brucellosis nor the potential risk of
zoonotic spread to humans is known.
There has been interest in human brucellosis caused by B. canis
among the public health community. However, the degree of public health
importance of human B. canis infections has not yet been ascertained.
The Council of State and Territorial Epidemiologists approved a
position statement in 2012 that recommends increased focus on B. canis,
and urges CDC to support the development of a human diagnostic assay.
The purpose of this information collection request is to estimate
the burden of canine brucellosis in the United States, which will aid
in the determination of the level of public health importance of human
B. canis infections, and the potential for transmission of brucellosis
from dogs. An estimate of disease burden in dogs will provide an idea
of potential transmission between dogs and humans, and determine the
need for future human public health studies, which is critical during
this time of scarce resources.
Veterinary diagnostic laboratories throughout the United States
will be solicited to provide information on the quantity of test
requests and positive results for Brucella spp. in canines, outsourcing
of clinical testing, state-wide policies for reporting of positive
results, and policies for human exposure to clinical specimens or
isolates.
The laboratories were identified through multiple sources: A review
of the Animal and Plant Health Inspection Service-approved Brucella
diagnostic laboratories, the National Animal Health Laboratory Network
laboratories, the American Association of Veterinary Laboratory
Diagnosticians (AAVLD), and an Internet search.
The outcomes of this information collection are to assess the
burden of disease in the animal host (dogs, in this case), as well as
evaluate the knowledge and practices of occupational exposures to the
organism. The information collected will be used to guide a longer term
strategy for identification of human cases, understanding risk factors
and activities associated with zoonotic transmission, and eventually
validation of a human diagnostic assay. These strategies will be
implemented using other mechanisms.
The total annual burden is 129 hours.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hrs.) (in hrs.)
----------------------------------------------------------------------------------------------------------------
Veterinary diagnostic Burden of Canine 119 1 1 119
laboratory staff. Brucellosis
Information
Collection.
Other laboratories............ Burden of Canine 10 1 1 10
Brucellosis
Information
Collection.
---------------------------------------------------------------
[[Page 28617]]
Total..................... ................ .............. .............. .............. 129
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2015-12094 Filed 5-18-15; 8:45 am]
BILLING CODE 4163-18-P
